NBIX Neurocrine Biosciences, Inc.

156.59USD-3.85%Mkt Cap: 15.85B USDP/E: 23.23

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products i…